International leader in precision medicine to join Texas A&M through Governor’s University Research Initiative 

Kenneth Ramos named executive director of Institute of Biosciences and Technology, assistant vice chancellor for health services 

BRYAN, Texas — Kenneth Ramos, MD, PhD, PharmB, an accomplished physician-scientist and internationally recognized leader in genomics, precision medicine, environmental health and toxicology, will join Texas A&M University Health Science Center in March to lead the Institute of Biosciences and Technology(IBT) in Houston and serve as assistant vice chancellor for health services at The Texas A&M University System. Ramos will join the university through the Governor’s University Research Initiative(GURI), enacted by Governor Greg Abbott in 2015 to attract transformative researchers to the state of Texas. 

"The Lone Star State has long been a leader in science and healthcare, and the addition of the internationally recognized Dr. Ramos to the Texas A&M University Health Science Center to lead the Institute of Biosciences and Technology will further strengthen our state’s progress in these fields,” said Governor Abbott. “I have no doubt that the Texas A&M University System and the state as a whole will benefit greatly from his invaluable experience and wealth of knowledge from his years of research and time at the National Academy of Sciences. This grant represents Texas’ continued commitment to a world class workforce, excellence in higher education, and a diversified economy.”

            The initiative provides up to $5 million in matching funds per researcher to assist eligible institutions of higher education in Texas to recruit distinguished scholarswho will, in turn, serve as economic catalysts to the state’s economy for years to come.

            “We at The Texas A&M University System appreciate Gov. Abbott for helping us to land such a gifted scientist and physician,” said Texas A&M University System Chancellor John Sharp said. “Dr. Ramos’ experience—including his work with veterans and his background in cancer research—makes him an ideal fit for the Texas A&M University Health Science Center and the Institute of Biosciences and Technology.”

Ramos was designated an associate of the National Academy of Sciencesin 2008 and elected to the National Academy of Medicinein 2015. He comes to Texas A&M from the University of Arizona Health Sciences, where he was associate vice president for precision health sciences and executive director for the Center for Applied Genetics and Genomic Medicine. He has training in pharmaceutical sciences, chemistry, biochemistry, pharmacology and medicine.

“The Texas A&M Health Science Center enthusiastically welcomes Dr. Ramos,” said Carrie L. Byington ’85, MD, vice chancellor for health services at The Texas A&M University System, senior vice president of the Texas A&M Health Science Center and dean of the Texas A&M College of Medicine. “His leadership and vast experience advancing health care through precision medicine, research, and new technology will benefit the IBT and will support the expansion of the Health Science Center in Houston. Dr. Ramos will be instrumental in further developing our research partnerships through our founding membership in the TMC3. He will join our leadership team supporting our research initiatives in Houston and across the state.”

Precision medicine, which takes into consideration an individual’s genes, environment and lifestyle during diagnosis, treatment and prevention, is a specialty of Ramos’. 

“Precision medicine is new in terms of recognition but has actually been practiced since the beginning of time,” Ramos said. “We’ve always done the best that we can to see our patients as individuals, but now we have new tools and technologies to add insight we wouldn’t otherwise be able to get.” 

Ramos focuses most of his practice on chronic obstructive pulmonary disease(COPD). He consults with other physicians about their patients and helps them identify those who might be at a higher risk of lung cancer or worsening clinical outcomes.

 “Texas A&M is an outstanding institution with a tremendous legacy, and I’m looking forward to the opportunity to help transform the health care space in Texas and beyond,” Ramos said. 

###

About Texas A&M University Health Science Center
Texas A&M University Health Science Center is transforming healththrough innovative research, education and service in dentistry, medicine, nursing, pharmacy, public health and medical sciences. As an independent state agency and academic unit of Texas A&M University, the health science center serves the state through campuses in Bryan-College Station, Dallas, Temple, Houston, Round Rock, Kingsville, Corpus Christi and McAllen. Learn more at vitalrecord.tamhsc.edu or follow @TAMHSC on Twitter.


6 Ways to Celebrate Singlehood this Valentine’s Day 

Columbia University Affiliated Neuropsychologist with Empowering Tips and Insights

Image

www.comprehendthemind.com

These days, more and more women are referring to Valentine’s Day as “Single Awareness Day.” Gone are the days of moping around lonely and longing for a relationship. Many women who are fulfilling career ambitions, focusing on meeting financial goals, traveling and having fun with friends and family are perfectly fine with their singleness. When Valentine’s Day rolls around, more single women want to treat it as an excuse to have some fun. To keep the positive momentum going, Dr. Sanam Hafeez, Neuropsychologist and Teaching Faculty at Columbia University, shares 6 positive ways to celebrate singlehood this Valentine’s Day. 

1. Plan a trip.

While everyone else is out getting overpriced meals and mediocre service, declare a date-night with yourself setting the goal to plan a solo trip to see friends or family or explore another city. Many single women make the mistake of forgoing travel because they want a boyfriend to travel with. They end up burning themselves out with too much work and no play. “Planning a trip is a fun forward-thinking activity that inspires creativity, imagination, and optimism. When you are single you have the freedom to travel the way you want. You don’t need to consider anyone else.” explains Dr. Hafeez. 

2. Spruce up your surroundings.

When we get into nesting mode, we honor ourselves and our single status. Tidying up and simply adding new throw pillows to a sofa, a new bedspread, a new shower curtain, and some candles can add new energy to your space. “Another great way to celebrate your singlehood on Valentine’s Day is to decorate as you see fit. When we feel great in our living space, we are more productive. Many single women find they enjoy being able to redecorate without having anyone else offering their opinion.” Dr. Hafeez adds. 

3. Host a party.

Celebrating Singlehood on Valentine’s Day can be a blast when you invite other singles over for a fun pot luck dinner or cocktail party. Share funny dating stories, play some great music and enjoy some quality time with friends. “When people enter relationships, they have less time for their friends. Single people who have a solid group of friends always have something fun going on. What is interesting is the more a person loves their single life, is confident and happy on their own, the more attractive they become to others,” explains Dr.Hafeez.

4. Pamper yourself.

Schedule your hair cut, facial, massage and declare a day of self-pampering. Many salons and spas offer Valentine’s Day specials and packages so take advantage. Some even offer after work treatments so you can go straight from work and indulge. “Treating yourself to a day of beauty is a great way to tend to yourself. Single women have the time to focus on their beauty routines without anyone asking how much they spend on eyebrow waxing, facials, highlights, blow-outs and anything else you choose to do,” Dr.Hafeez reminds us. 

5. Go shopping… online.

Be your own Valentine and buy yourself a present or several presents for that matter? Perhaps there’s a nice dress, handbag, shoes or fragrance that you’ve been wanting to treat yourself to. Celebrate your awesomeness with a splurge. “When we shop, we get a dopamine hit, hence the term retail therapy. The key is not to let it get out of control. Set a budget and the intention to enjoy yourself. Buy yourself something that a man typically would such as jewelry. There’s something very empowering about a woman buying herself a beautiful and symbolic piece of jewelry, suggests Dr.Hafeez. 

6. Eat the candy.

Who doesn’t love chocolate? You’re your own greatest Valentine! Grab yourself your favorite Valentine’s Day candy box and allow a sweet treat. “Want an endorphin boost? Eat some chocolate. Endorphins are stress minimizers and help boost our immune systems,” says Dr.Hafeez. Ladies who revel in their singlehood have no problem treating themselves to some chocolate covered berries and champagne. 

Cheers to you and cheers to being single. 

About the Doctor:

Dr. Sanam Hafeez PsyD is an NYC based licensed clinical psychologist, teaching faculty member at the prestigious Columbia University Teacher’s College and the founder and Clinical Director of Comprehensive Consultation Psychological Services, P.C. a neuropsychological, developmental and educational center in Manhattan and Queens. Dr. Hafeez masterfully applies her years of experience connecting psychological implications to address some of today’s common issues such as body image, social media addiction, relationships, workplace stress, parenting and psychopathology (bipolar, schizophrenia, depression, anxiety, etc…). In addition, Dr.Hafeez works with individuals who suffer from post-traumatic stress disorder (PTSD), learning disabilities, attention and memory problems, and abuse. Dr.Hafeez often shares her credible expertise to various news outlets in New York City and frequently appears on CNN and Dr.Oz. Connect with her via Instagram @drsanamhafeezor www.comprehendthemind.com

Uncovering Our Natural Strengths To Live Up To Our Fullest Potential

Discovery Bay, CA, January 28, 2019 — For anyone wanting to reach their full potential but uncertain how to begin, The Gifted Journey: Five Transformative Steps to Uncovering Your Unique Path by Gallup-certified strengths coach Stephanie Moore provides the necessary tools to make it a reality. Moore's proven steps to finding our own path to living a more purposeful, joy-filled life are based on decades of personal experience in career development. 

Moore stays focused on all things positive, as she introduces her actionable five-step process designed to help readers Discover, Discern, Dream, Design and Do what they were always meant to do based upon their natural strengths—their gifts.

Each of the five steps contains exploratory exercises that walk readers through personal reflection and the gathering of objective perspectives from trusted colleagues and friends. The result is a blend of self assessments and external input that makes The Gifted Journey uniquely adaptable to the needs of each individual. 

Along the way, Moore shares professional and personal anecdotes to help drive home her impactful message that through embracing our authentic skill sets, we can move toward more promising futures with renewed passion and enthusiasm. 

The Gifted Journey is for anyone questioning their direction in life, including those about to apply for colleges, those just starting out in their careers, downsizing statistics, or those who are simply unhappy with their current path and need some course correction. Each of these situations can be a powerful catalyst to seeking change, and the five steps in The Gifted Journey can help readers uncover their gifts and put them to work. 

Stephanie Moore is a Gallup-certified strengths coach with more than two decades of experience in leadership development, career consulting and executive coaching. As a strengths-based practitioner, she has used her unique blend of expertise, passion and spirituality to help thousands of people discover more fulfilling and rewarding career paths. She has designed and currently delivers the highly successful and comprehensive development courses, Strengths-Based Development and Strengths-Based Teams, to organizations, universities and associations across the globe. 

She launched The Moore Group, Inc., in 2000 and cofounded the nonprofit Catholic Strengths and Engagement Community in 2008. She is a native of Northern California and holds a bachelor's degree in psychology from St. Mary's College in Moraga, California. She is also a graduate of the School for Pastoral Ministry through the Diocese of Oakland. She is currently developing a series of retreats and workshops that follow The Gifted Journey process. 

For more information, please visit www.thegiftedjourney.com.

The Gifted Journey: Five Transformative Steps to Uncovering Your Unique Path
Inspired Forever Book Publishing
Released: September 2018
ISBN-13: 9780999625880 
ISBN-13: 9780999625897 
Available from Amazon.com and other e-book retailers

Q & As available on request

Reviews:

Fredrick Gilbert, Ph.D., Let'er Rip Productions – "… Whether you are starting out life in high school or making major mid-life changes this book is the tool belt that will help you construct your future. It is all here: self-assessment tools; exercises to understand your strengths and passions; ways to evaluate where you fit into the world of work. Stephanie's writing style is so accessible. She feels like an old friend who is being straight with you by letting you inside her own life-changing struggles. … If you are struggling to understand how your past can chart your future happiness, read this book. Do the exercises. Put it into action. Then write a thank you note to Stephanie.”

Mary McGlynn, president and VP of learning, development and research, PowerSpeaking, Inc. – "Stephanie Moore's The Gifted Journey serves as your personal archaeologist. As you proactively become a searcher of clues, a seeker of patterns, and a creator for your own fulfilled future, you find the path to your own career satisfaction. With assessments, tools, and exercises, your story unfolds in a magical way.”

Jo Ann Miller, OSF Strengths Development Center, former 40-year Gallup employee – "The Gifted Journey, is an amazing contribution! As Stephanie shares from her own gifted journey, she will lead you to discover your own 'conscious competence' at whatever time in your life you meet her invitation. When individuals truly work in their 'strengths zone,' it feels 'just right to them and others like it too.' One can feel Stephanie's joy and pleasure—not only in her own life's multifaceted talent discoveries, but in her day-to-day experience of living them out. Walk with Stephanie through her 5-D strategy for life's journey. Find a GIFT on every page as you 'learn, love and live' your gifted journey.”

Rick Fersch, former president and CEO of Eddie Bauer – "The 'WOW' moment in this book is when you recognize that each day is a gift waiting to be opened and discovered. I strongly subscribe to Stephanie's thesis that our life journey should be used to uncover and emphasize our strengths—and to build upon these gifts for a more fulfilling and promising future. Executing this 5 stage process will allow us to live the life that was always intended just for us. I was a business leader for over 30 years, and as president and CEO of Eddie Bauer, I suffered a life threatening stroke that changed my world and led me to embrace these stages. Using this process allowed me to discern how best to change my course, and how to apply my gifts to the faith world as Executive Director of Stewardship and Development at the Archdiocese of Seattle. Through living my own life journey, I can readily embrace and endorse Stephanie's well laid out process. It is both refreshing and innovative—building on widely known and successful concepts for helping to find your true self. Her unique and easy to read format allows you to execute action points that help support your master life plan.”

5,000+ paramedics in six provinces to provide palliative care in the home

New training for paramedics will increase access to palliative care in the home for patients and families, where they want it

TORONTO, Jan. 29, 2019 /CNW/ - The Canadian Partnership Against Cancer (the Partnership) and the Canadian Foundation for Healthcare Improvement (CFHI) today announced that Canadians living with cancer and other life-limiting conditions will gain access to urgent palliative care when they need it, and where they want it. This will be achieved through paramedics trained in providing palliative and end-of-life care in the home, in collaboration with other health professionals. 

Teams announced: The two organizations will provide funding and support to train over 5,000 paramedics to provide palliative and end-of life care in:   

  • BC Emergency Health Services 
  • Saskatchewan Health Authority Regina Area 
  • Interlake-Eastern Regional Health Authority (Manitoba) 
  • York Region Paramedic Services (Ontario) 
  • Ottawa Hospital Research Institute 
  • New Brunswick Department of Health 
  • Eastern Health (Newfoundland and Labrador)

Evidence shows that having paramedics provide palliative care and end-of-life care in the home improves comfort and quality of life for people with debilitating illnesses, as well as their families.1 It also reduces the number of avoidable trips to the hospital and the use of health system resources, such as hospital beds and emergency departments and total time on a call for paramedics.1

The Paramedics and Palliative Care: Bringing Vital Services to Canadians collaboration will run until spring 2022. This program is part of ongoing efforts by the Partnership and CFHI to improve Canada's health system and ensure it responds to the needs of patients and families. It also supports the shared health priority of improving access to home and community care, including palliative and end-of-life care. 

The two organizations will jointly provide up to $5.5 million over the next four years to expand access to paramedics trained in providing palliative and end-of-life care to people in their homes. CFHI and the Partnership will support provincial health authorities and organizations across the country to adopt and adapt best practices.

Quick facts

  • 86 per cent of Canadians believe palliative care should be provided at home as much as possible.2
  • Of Canadians who have a preference, 75 per cent would prefer to die in their home.3
  • Few Canadians (15 per cent) have early access to palliative home care.4
  • 62 per cent of Canadians who received palliative care did so in an acute care hospital and mostly in their last month of life.4
  • People who receive palliative care earlier are less likely to visit emergency departments frequently or receive aggressive treatment at the end of life.4
  • 65–80 per cent of people receiving palliative care are those with cancer.5

Quotes

"A big part of achieving a more sustainable cancer system is finding ways to have vital supports provided to patients in their home and community," said Cindy Morton, CEO of the Partnership. "Paramedics and Palliative Care is a big step in achieving this home-based support and we are excited to collaborate with CFHI to deliver these skills to paramedics across the country."

"We know that a majority of Canadians want access to palliative and end-of-life care in their homes," said Jennifer Zelmer, President and CEO of CFHI. "That is why we are pleased to work together with the Partnership and the participating provincial health authorities and organizations to bring palliative and end-of-life care closer to home, responding to the preferences of patients and families and making better use of healthcare resources." 

"Introducing this model of care in Nova Scotia and Prince Edward Island has improved access to palliative care 24 hours a day, 7 days a week across our two provinces.  Paramedics feel this is some of the most rewarding work they do, and patients and families describe the relief they feel being more able to remain home with the support of this new program," said Dr. Alix Carter, Medical Director of Research at EHS Nova Scotia and member of the Paramedics Providing Palliative Care at Home Program team in Nova Scotia and Prince Edward Island. "I am so pleased that CFHI and CPAC are supporting this collaboration of paramedic services and palliative care to enable patients and families in many more regions across Canada to have this support."  

"Access to quality palliative care services is essential for Canadians facing life-threatening and debilitating illnesses," said the Honourable Ginette Petitpas Taylor, Minister of Health. "The recently released Framework on Palliative Care in Canada highlights the need to expand innovative projects like this one, which improve person-centred care and access to palliative care where and when it is needed."

Related links:  Backgrounder

About the Canadian Foundation for Healthcare Improvement
CFHI works shoulder-to-shoulder with partners to identify proven innovations and accelerate their spread across Canada, improving patient care, the health of everyone in Canada and value-for-money. CFHI is a not-for-profit organization funded by Health Canada. Visit cfhi-fcass.ca for more information.

About the Canadian Partnership Against Cancer
As the steward of the Canadian Strategy for Cancer Control (the Strategy) the Partnership works to implement the Strategy to reduce the burden of cancer on Canadians. The partner network – cancer agencies, health system leaders and experts, and people affected by cancer – brings a wide variety of expertise to every aspect of our work. After 10 years of collaboration, we are accelerating work that improves the effectiveness and efficiency of the cancer control system, aligning shared priorities and mobilizing positive change across the cancer continuum. The Partnership continues to support the work of the collective cancer community in achieving our shared 30-year goals: a future in which fewer people get cancer, fewer die from cancer and those living with the disease have a better quality of life. The Partnership was created by the federal government in 2006 to move the Strategy into action and receives ongoing funding from Health Canada to continue supporting partners from across Canada. Visit www.partnershipagainstcancer.ca.

The views expressed herein do not necessarily represent the views of Health Canada.

REFERENCES

1-       Carter AJE, Arab M, Harrison M et al.  Paramedics Providing Palliative Care at Home: A Mixed-Methods Exploration of Patient and Family Satisfaction and Paramedic Comfort and Confidence. CJEM 2018 in press
2-       Canadian Partnership Against Cancer. Canadians' Views of Palliative Care. 2016. Available at: https://static1.squarespace.com/static/5755e91b044262d8f43cf6fa/t/58209f5ef7e0abaa8f492eb7/1478532961492/Roulston-Ipsos.pdf
3-       What Canadians Say: The Way Forward Survey Report December 2013. Available at: http://www.hpcintegration.ca/media/51032/The%20Way%20Forward%20-%20What%20Canadians%20Say%20-%20Survey%20Report%20Final%20Dec%202013.pdf
4-       Access to Palliative Care in Canada. Canadian Institute for Health Information. 2018. Available at: https://www.cihi.ca/sites/default/files/document/access-palliative-care-2018-en-web.pdf 
5-       Canadian Society of Palliative Care Physicians. How to improve palliative care in Canada: A call to action for federal, provincial, territorial, regional and local decision-makers. November 2016. Available at: http://www.cspcp.ca/wp-content/uploads/2016/11/Full-Report-How-to-Improve-Palliative-Care-in-Canada-FINAL-Nov-2016.pdf

SOURCE Canadian Partnership Against Cancer

FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-Class WDR5 Leukemia Therapy

Largest transaction to date for Canadian-discovered preclinical asset arises from Ontario collaborators 

TORONTO, Jan. 29, 2019 /CNW/ - Triphase Accelerator, together with its majority shareholder FACIT, today announced a new strategic collaboration with Celgene for a first-in-class preclinical therapeutic targeting the WDR5 protein for the treatment of blood cancers including leukemia. Triphase is a drug development company advancing novel compounds through Phase 2 proof-of-concept, including the WDR5 program.

Under the terms of the agreement, Celgene has the option to acquire TRPH-395 from Triphase Accelerator. Celgene will pay an upfront of US$40M and upon exercise of the option, Celgene will pay up to US$940M in contingent development, regulatory and sales milestones. Additional payments for sales-based royalties are also possible.

"As with our previously announced spin outs, the Drug Discovery team at Ontario Institute for Cancer Research (OICR), led by Dr. Rima Al Awar, has yet again produced a world-class asset for patients with cancer," remarked Dr. David O'Neill, President of FACIT. FACIT seed financed Propellon Therapeutics to commercialize the preclinical asset and ran a competitive global business development process to identify strategic partners. Multiple formal offers were received from the US, Europe and Japan, reflecting the high quality of science in the program.

Dr. O'Neill continued "The quality of the team and commitment by Triphase Accelerator to engage Ontario researchers and clinical sites in its high content studies, combined with its long-standing relationship with Celgene made this partnership the most compelling path to impact patients and the local economy." While additional payments to the program are largely contingent on clinical success, the significant financial commitment will enable re-investable returns by FACIT in the Ontario innovation economy.

The WDR5 protein is critical for the formation and activities of certain protein complexes that are associated with DNA and indirectly modify genes. These processes represent an exciting new therapeutic field, referred to as epigenetics. Blood cancers like leukemia can result when WDR5-associated protein complexes are not appropriately regulated in the body. Drug compounds that can disrupt these cancer-causing cellular activities represent a novel therapeutic approach, which may also improve clinical outcomes in patients with solid tumours.

"This transaction represents a significant milestone for Triphase Accelerator as it brings together our long-standing collaboration with Celgene and a first-in-class asset from Ontario" said Dr. Ilse Treurnicht, Executive Chairperson at Triphase Accelerator. "We are excited that this transaction is another step forward to realizing the vision of the founding partners – OICR, MaRS Innovation and MaRS – and will allow Triphase to apply its unique science based, rapid, and cost-effective approach to advancing this Ontario based program toward clinical proof of concept."

"Our investment in Propellon's technology reflects our commitment to developing first-in-class epigenetic therapies for patients with hematological cancers," remarked Dr. Jorge DiMartino, Vice President of Translational Development at Celgene.  "The teams at OICR Drug Discovery, FACIT and Triphase Accelerator have together created an optimal pathway for oncology innovation and help make Ontario a strong collaborator and destination for our investment."

"This is a great day for cancer research in Ontario. Congratulations to FACIT, OICR and Triphase Accelerator," said Todd Smith, Minister of Economic Development, Job Creation and Trade. "This discovery and investment will benefit Ontario cancer patients and support industry jobs in the province. Ontario is open for business, and we welcome more innovative cancer research and trials."

"This is an exciting development for cancer research and innovation in Ontario, and I congratulate FACIT, OICR and Triphase Accelerator on their important collaboration," said Christine Elliott, Deputy Premier and Minister of Health and Long-Term Care. "It's partnerships like these that keep Ontario open for business and are invaluable as we work toward developing a long-term transformational health care strategy guided by innovation, integration and the better use of technology."

About Triphase Accelerator
Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to advancing novel compounds through Phase 2 proof-of-concept clinical studies using a unique, science-based model that is faster and more cost-effective than traditional pharmaceutical and biotech industry drug development approaches. Triphase Accelerator was founded by the Ontario Institute for Cancer Research (OICR), in partnership with MaRS Innovation and MaRS. It has a strategic relationship with Celgene for oncology-focused drug development opportunities. In 2016, Celgene acquired the company's assets related to its proteasome inhibitor, marizomib (MRZ), which is currently in Phase 3 development for glioblastoma. For more information, visit www.triphaseco.com or LinkedIn.

About Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. For more information, please visit www.celgene.com.  

About FACIT       

FACIT builds companies with entrepreneurs to accelerate oncology innovation and its portfolio has attracted over a half billion dollars in investment to Ontario. Blending industry experience, capital and the unsurpassed clinician-scientist network of its strategic partner the Ontario Institute for Cancer Research (OICR), FACIT capitalizes on the province's investment in research and healthcare to the benefit of the local economy and patients worldwideFACIT's commercialization portfolio includes Turnstone Biologics, Fusion Pharmaceuticals, Triphase Accelerator and other biotechnology organizations. Cancer Breakthroughs. Realized. facit.ca.

SOURCE FACIT

A New Era in the Fight Against Breast Cancer

Oncologist Discusses First-Of-Its-Kind Treatment Option for Early-Stage Breast Cancer Interviews Available with Elizabeth M Nichols, MD, Assistant Professor of Radiation Oncology at the University of Maryland School of Medicine, Clinical Director, Department of Radiation Oncology at the University of Maryland Medical CenterFriday, Feb. 1, 2019 from 7:00 AM - 12:30 PM ET Early detection and treatment have yielded high survival rates for women diagnosed with early-stage breast cancer.  However, standard radiation techniques can present significant challenges for patients, especially those who must undergo weeks of daily treatments. A new FDA-cleared treatment method developed by doctors and scientists at the University of Maryland School of Medicine could provide an alternative for some diagnosed with this disease – one that could shorten radiation treatment from weeks to days. The GammaPod, a unique radiation system designed to treat early-stage breast cancer by targeting the cancer and limiting damage to other organs, is part of a growing movement in oncology to try to reduce the amount of treatment to help curb side effects, improve quality of life and prevent patients from being overtreated.    In interviews, Dr. Elizabeth Nichols, MD will discuss early-stage breast cancer, the problem of overtreatment, benefits of partial breast radiation and who is a candidate for the GammaPod. About Elizabeth M Nichols, MD Dr. Nichols is an assistant professor of radiation oncology at the University of Maryland School of Medicine, clinical director of the University of Maryland Medical Center Department of Radiation Oncology and chair of the GammaPod Consortium.  Dr. Nichols specializes in treating breast and gynecologic cancers.

Anxiety, It's Time to Go: New Book Ditches the Psychobabble to Remove Anxiety…for Good! 

Kevin Mullin’s ‘Anxiety, It’s Time to Go’ calls on the author’s vast experience as an NLP practitioner to help readers identify the root of their anxiety and not only remove it…but rid it for good. Using a series of proven techniques, this breakthrough guide could just be the most com

Ayr, Scotland – Those who suffer from anxiety and its related disorders understand it isn’t just disheartening, but an often-debilitating, life-destroying condition. And even worse, there’s a flood of books on the market conveying half-baked techniques that rarely actually work.

But that all now stops thanks to NLP practitioner Kevin Mullin and his new book, ‘Anxiety, It’s Time to Go’.

Just like the title, Mullins’ breakthrough text marks anxiety’s “grand finale” for its sufferers around the world, as they prepare to step into a new life free of the condition.

Synopsis:

Anxiety, It's Time to Go is not just another self-help book. It is 'the' self-help book. It uses cutting-edge tried and tested methods that have been used time and time again to remove anxiety from people each and every day. Anxiety, It's Time to Go will explain everything in simple terms and then show you exactly how to combat the things that hurt and control us when it comes to anxiety. The easy-to-follow exercise and instructions have been made straightforward without all the psychobabble that most people use. We say it as it is and then show you exactly how to remove it. This might just be the best thing you have done when it comes to beating crippling anxiety once and for all. 

“The over-riding goal with this book was to make it as straightforward and actionable as possible, with no fluff and no BS,” explains the author. “The fact of the matter is that anxiety is an epidemic in society these days and, unless someone steps in to do something about it, it’s going to continue destroying lives around the world.”

Continuing, “You need no prior understanding of NLP to use my book to change your life, and you also don’t need to fully understand your own anxiety. If you suffer, or even think you do, what I have to teach will radically improve your mental health and the overall quality of your life. Get a copy today!”

Reviews have been extremely positive. One reader writes, “I was given the book to read and I loved it. It was one of those books that I did not want to put down but equally did not want to finish, as I was enjoying it too much (like saving a new dress 'for best'). It was all so simple, it made sense and it worked!!! Now, I am not going to elaborate more, because I am now too busy living anxiety-free! Too busy enjoying life. Planning life. Too happy to even think about the old me who wasted so much time feeling anxious, stressed, miserable, not wanting to be here. So, read it for yourself.”

‘Anxiety, Its Time to Go’ is available now: https://amzn.to/2DvLkDQ

About the Author:

Kevin Mullin enlisted in the British Army aged fifteen years and eight months. He served in several conflict areas and operations around the globe, then at the age of thirty-four, he left the service and became a private military operator. Kevin was contracted to the United States Department of Defense, securing and protecting US Military bases and assets in Afghanistan. Kevin worked there for four years before moving to one of the most valuable targets in Afghanistan in the heart of Kabul – The Serena Hotel. Kevin studied NLP within the British Army and gained a wealth of knowledge and experience, training the trainers in the methods of approaches to NLP. Having suffered the loss of both his brother and mother, he was crippled with anxiety for many years. Kevin searched relentlessly for new, dynamic ways to beat it.

Having taken an apprenticeship with Ali Campbell, Kevin finally found what he was looking for. He understudied and role modelled Ali to great effect. In June 2017, Kevin opened his very own NLP practice based in Central Scotland. The practice has received rave reviews about Kevin’s new, dynamic and direct approach. He has helped thousands of clients become anxiety-free. Kevin has gained plaudits from Italy, Dubai and America for his dynamic and enthusiastic approach to motivational speaking and helping businesses and organisations flourish and grow. He is also a full-time parent. He raises his children with the approach he takes in life and in his crusade to help everyone in the battle with anxiety. Drive, determination and a vigour unparalleled in this modern age.

GeneNews Publishes Data on ColonSentry® in Colorectal Cancer Risk Assessment

Study demonstrates validity of blood-based biomarker test as an adjunct method to colon cancer screening tests in non-compliant patient populations

TORONTO, Jan. 28, 2019 /CNW/ - GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") today announced it has published a new study that further validates the stability of its proprietary test, ColonSentry®, as a tool to risk stratify patients who are non-compliant with any form of Colorectal Cancer screening and prioritize patients who should be referred directly for colonoscopy versus other modalities for colorectal cancer screening. The paper, "Stability of the ColonSentry Colon Cancer Risk Stratification Test" appears in the current online edition of International Journal of Disease Markers.

ColonSentry is a proprietary liquid biopsy test that uses advanced gene expression technology for the early identification of Colorectal Cancer (CRC). Initially developed in 2008 from a clinical study involving approximately 10,000 subjects in North America, ColonSentry was broadly commercialized in 2014 and has been administered to over 100,000 patients throughout the U.S. The ColonSentry test is the first commercially available test that uses GeneNews proprietary science, the Sentinel Principle. The Sentinel Principle is based on the scientific observation that circulating blood reflects, in a detectable way, what is occurring throughout the body and underpins the Aristotle program, which is focused on detecting ten cancers from a single sample of blood.   

The study's authors compared real-life distribution of the results against the model that was initially developed and reviewed them in the context of measurement stability, and to evaluate the validity of the assumptions made during the construction of the mathematical model. The model's assumption of two subpopulations, one with colorectal cancer at 0.7% prevalence, and the other without colorectal cancer at 99.3% prevalence, fit the data within the expected measurement tolerances. Research also explores enhancement of the model to address a precancerous polyp phase subpopulation, and how the test results can be used to identify patients who should be referred directly for colonoscopy versus other modalities for colorectal cancer screening.  The study confirmed that ColonSentry can be used to determine, from a blood sample, whether patients are at elevated risk for colorectal cancer and detects left and right-sided lesions with similar sensitivity. ColonSentry can be considered for use as an alternative method in non-compliant patient populations. 

According to the study's lead author, Robert Burakoff, MD, Site Chief for the Division of Gastroenterology and Hepatology at New York-Presbyterian Lower Manhattan Hospital and Weill Cornell Medicine, "The clinical utility of ColonSentry is significant. A routine blood test for patients who have yet to comply with any form of colorectal cancer screening can be a game-changer in identifying those at elevated risk for the disease and motivating them to have their colonoscopy. In addition, routine use of a blood test that detects both left-sided and right-sided lesions can increase the effectiveness of colorectal cancer screening by revealing the potential presence of neoplasms in advance of colonoscopy."

James R. Howard-Tripp, GeneNews' Chairman and CEO further commented "Finding colorectal cancer early is critical and alters the 5-year survival rate from 11% if found late, to 91% if found early. Additionally, a diagnostic test must be convenient and patient friendly if we are going to successfully address the 33% of patients who are non-compliant with CRC screening. ColonSentry fulfills this role, and this confirmatory study on 100,000 at-risk patients demonstrates the robust nature of the test." 

ColonSentry requires a simple, in-office blood draw. If the ColonSentry score is elevated in a patient at average risk, there is an increased probability the patient may have a pre-cancerous lesion or colorectal cancer. Patients with an elevated ColonSentry score are referred for further evaluation.

According to the American Cancer Society, Colorectal cancer is the third most common cancer diagnosed in men and women in the U.S. Approximately 140,000 people are diagnosed each year, and more than 50,000 people are estimated to die from the disease.

About GeneNews

GeneNews, an innovator in the liquid biopsy space, is committed to becoming a leader in advanced diagnostics and personalized medicine, serving as a strong commercialization outlet for early detection of cancer and other chronic diseases. Our mission is to identify, assess and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with personalized clinical intelligence and actionable information to improve health out-comes through the early diagnosis of disease. Our Richmond, Virginia-based clinical reference lab, Innovative Diagnostic Laboratory (IDL) specializes in advanced molecular diagnostics that helps find, understand, and address cancer risk in patient populations. Currently, IDL offers risk assessment blood tests for four prevalent cancer types - colon, lung, prostate and breast. GeneNews' common shares trade on the Toronto Stock Exchange under the symbol 'GEN'.  More information on GeneNews and IDL can be found at www.GeneNews.com.

Forward-Looking Statements

This press release contains forward-looking statements identified by words such as "expects", "will" and similar expressions, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties that could cause the Company's actual events to differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law.  

SOURCE GeneNews Limited


Why are Hot Showers So Beneficial for Sore Muscles?
After a big workout or another major physical activity, such as for moving furniture or packing boxes, muscles can become tight, sore, and painful. Individuals may notice that they have tight necks, sore arms and legs, and decreased flexibility. However, a hot, steamy shower may be just right for getting rid of sore muscles and getting back to normal within the next day or two.

Loosen Tight, Sore Muscles
The first and most obvious benefit of hot showers for muscles is their loosening of tight muscle fibers. After a big workout, the muscles often become tight, tense, and inflexible because of the buildup of lactic acid in them. Hot water helps to open up the fibers, allowing lactic acid to be washed away and decreasing any pinching sensations around nerves that run through the muscles.

Increase Blood Circulation
Hot water also improves circulation by widening the blood vessels. When more blood can get to an area, the area will heal faster, and muscle fibers will find it easier to repair themselves. A hot shower can also be beneficial in the morning before a workout because it helps to loosen up the body with improved circulation, limiting the chance for injuries during a workout.

Get Hot Water All the Time
Family members who are not getting enough hot water to complete a relaxing shower or who find that the hot water is gone before may feel frustrated. This may mean that you might possibly need to look into getting a new water heaterfor the household. New Energy-Star rated water heaters can save money while also heating water faster than ever. Individuals should be sure to choose a heater capacity that matches the number of people in the household.

Decrease Overall Stress
Hot showers are about more than just physical benefits for muscles. As the hot water washes over the body, a sensation of letting go often occurs as well, leading to less stress mentally. Decreased stress and anxiety can also indirectly help loosen muscles.
Of course, hot showers are beneficial for more than just muscles. They can also open congested sinuses, improve skin color and tone, and warm up a body that is cold during the winter. However, when used for sore muscles, hot showers can be incredibly beneficial by warming up the entire body at once while also including the calming effect of the water running over the skin. For a non-serious injury, heat can truly be a powerful and effective treatment.

General Manager Robert De Clark Announces Four New Appointments at Homewood Ravensview

Leading interdisciplinary experts join Homewood's groundbreaking new mental health and addiction treatment centre in BC in advance of its opening in Spring 2019

VICTORIA, Jan. 24, 2019 /CNW/ - Homewood Health, Canada's leader in mental health, trauma and addiction treatment, welcomes on board four highly-skilled and accomplished experts to Ravensview, its newest treatment centre located in North Saanich, British Columbia.

Robert De Clark, General Manager of Homewood Ravensview, is proud of the talented team coming together to lead the development and delivery of the facility's innovative programs. 

"We are committed to supporting our clients in achieving positive outcomes, and providing medically-led, evidence-based care," says De Clark.  "Homewood Ravensview is committed to continuous, positive collaboration with the community and we're thankful to all the Islanders who have welcomed our presence."

Joining Robert De Clark and Dr. Lyn Macbeath, (previously announced as Ravensview's medical director) are the following new medical and clinical leaders at Homewood Ravensview. 

In the role of Clinical Director, De Clark welcomes Dr. Michael Berry R.PSYCH. Dr. Berry is a clinical psychologist with expertise in a variety of evidence-based assessments and treatments used to address mood/anxiety disorders, addictive behaviours, personality disorders and family issues. The clinical approach Dr. Berry uses is humanistic and integrative, taking a highly compassionate, down-to-earth approach, using humour, warmth, and evidence-based practices to help people.

Appointed to the role of lead psychiatrist is Dr. Kiri Simms BSCN, MD, FRCP(C). Dr. Simms is a renowned psychiatrist in BC and a Fellow of the Royal College of Physicians & Surgeons of Canada and an expert in emergency and crisis intervention, addiction treatment, medical psychiatry and the treatment of anxiety disorders. Her previous professional postings include clinical positions at the Douglas Mental Health University Institute in Montreal and the Vancouver Island Health Authority (Island Health). As a long standing and respected member of the Victoria medical community, Dr. Simms brings her extensive local experience and knowledge to Ravensview.

Dr. Paul Beckett MD, CCFP, DABAM, FASAM, CSAM joins Ravensview in the role of Addiction Physician. A specialist in addiction and family practice, Dr. Beckett worked for a decade as an ER physician and also directed medical care at many addiction centres (Maple Ridge Treatment Centre, Creekside Withdrawal Management and Hannah House). For over eleven years, Dr. Berry also provided physician services to multiple BC Correction Centres. 

Alexis Winter RPN, BA has been appointed as Ravensview's Director of Nursing. Ms. Winter is a Registered Psychiatric Nurse and a Master's Degree Candidate in Psychiatric Nursing who has extensive experience working with interdisciplinary health care teams in hospital, tertiary care and community outreach settings. Ms. Winter has also served as a director and the vice-chair of the College of Registered Psychiatric Nurses of British Columbia.

Homewood Health President and CEO, Jagoda Pike is equally enthusiastic about the Ravensview team.  "Our new medical and clinical leaders reflect Homewood's core values, and we are honoured to welcome them to Ravensview," said Ms. Pike.  "Their leadership and contribution to innovative program development will ensure life-changing treatment experiences for our many clients seeking a return to good health."

For more information about Homewood Ravensview or to learn additional details about the team, please visit the Centre's newly launched site: www.ravensview.com 

About Homewood Health

Homewood Health is Canada's leader in mental health and addiction services. With more than 135 years of experience, Homewood achieves outstanding outcomes through its national network of more than 4,500 employees and clinical experts. Homewood's complete suite of services includes organizational wellness, employee and family assistance programs, assessments, outpatient and inpatient treatment, recovery management, return to work and family support services, all customized to meet the needs of individuals and organizations. Homewood Health is redefining mental health and addiction services to help Canadians live healthier, more productive and more fulfilling lives.   

About Homewood Ravensview
Homewood Ravensview, part of Homewood Health, offers treatment for mental health, addiction and concurrent conditions. The Centre is located on 28 acres of forested hillside on Vancouver Island's Saanich Peninsula and focuses on creating individualized client experiences. Homewood Ravensview features forest and ocean views from private and semi-private bedrooms, suites and welcoming common areas.  Homewood Ravensview is scheduled to open in spring of 2019 with 75 beds and will employ more than 80 full-time staff.

Please visit www.ravensview.com for more information.

SOURCE Homewood Health Inc.